Optical Coherence Tomography Assessment of Gender diVersity In Primary Angioplasty. The OCTAVIA Trial

Acute Myocardial Infarction Clinical Trial

— OCTAVIA  

Official title:

Optical Coherence Tomography Assessment of Gender diVersity In Primary Angioplasty. The OCTAVIA Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01377207
• Other study ID #: 27/01/2011
• Status: Completed
• Phase: Phase 4
• First received: January 25, 2011
• Last updated: April 18, 2013
• Start date: January 2011
• Est. completion date: April 2013

Study information

• Verified date: April 2013
• Source: Italian Society of Invasive Cardiology
• Contact: n/a
• Is FDA regulated: No
• Health authority: Italy: Ethics CommitteeItaly: Ministry of Health
• Study type: Interventional

Clinical Trial Summary

Recent studies suggest important gender differences in the pathophysiology and prognosis of ST-segment elevation myocardial infarction (STEMI). This is the first prospective controlled study to assess gender differences in the mechanism of plaque rupture/erosion and thrombus formation in patients presenting with STEMI treated with primary angioplasty. Gender-related mechanisms of plaque rupture or erosion will be investigated using a combination of Quantitative Coronary Angiography, high resolution Optical Coherence Tomography of the culprit vessel and histopathologic analyses of thrombus aspirates of the infarct related lesion, performed by independent core laboratories, blinded to group (male or female) and clinical variables.

Description:

In OCTAVIA; enrollment in a 1:1 ratio according to gender group will be ensured by a computer-assisted matching algorithm for gender and age (< 50, 51-70, and > 70 years). Matching has the purpose to enable enrollment of an even number of male and female patients in balanced age groups. This type of dynamic algorithm is appropriate when the composition of the referral population is not known in advance.

OCTAVIA will assess gender differences in the mechanism of plaque rupture. The study will also evaluate the changes in the vascular territory remote from the infarct related lesion, the local vascular response to primary angioplasty interventions and the correlation with clinical outcomes over one year of follow-up. These data are important to support a gender based differential strategy and can have a substantial impact for the improvement of clinical practice in the treatment of women with STEMI.

The study sample of 140 patients is sized to address the hypothesis that the female population has a lower prevalence of plaque rupture (primary endpoint) at baseline OCT than the male population. Computations were conducted assuming a prevalence of rupture of 82% in males and 60% in female patients (22% lower).

Confirmatory power calculation was performed on the basis of stent Strut Coverage at 9 month follow-up (co primary endpoint). Stent-strut coverage and apposition have been linked to the risk of stent thrombosis. However, our understanding of DES healing in male and female patients with ST-segment elevation myocardial infarction is restricted to post-mortem data. The investigators assumed a per patient stent strut coverage (a continuous variable with right skewed distribution) with mean of 97.0% and standard deviation of 4.0% in men, versus mean of 95.0% and standard deviation of 4.0% in women, following Xience Prime implantation. Thus, aiming for a 5% 2-tailed superiority alpha, an 80% power, and assuming a 1:1 enrollment according to gender, a total of 64 patients per group should be enrolled. Anticipating a 10% dropout rate due to patients lost to follow-up and inadequate imaging (included major side branch sections), the total enrollment is set at 70 patients per group (total population of 140 subjects).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 140
• Est. completion date: April 2013
• Est. primary completion date: January 2013
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Acute Myocardial MI with ST segment Elevation, within 6 hours from symptoms onset

• Native coronary artery disease (no prior stent implant, no prior brachytherapy)

• Signed patient informed consent

Exclusion Criteria:

• Patients with left main disease

• infarct lesions in bypass grafts

• cardiogenic shock

• renal failure

• recent major bleeding

• allergy to aspirin or clopidogrel

• on anticoagulant therapy

• no suitable anatomy for OCT (extreme tortuousity, very distal culprit lesion, and large infarct vessel > 4 mm in diameter)

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Acute Myocardial Infarction
• Infarction
• Myocardial Infarction

Intervention

Procedure:
• Primary PCI
Thrombus aspiration and hystopathological analysis, Optical Coherence Tomography assessment of STEMI culprit vessel, Primary PCI with Drug Eluting Stent implantation; Repeat OCT assessment of culprit vessel at 9 monts follow-up

Locations

Country	Name	City	State
Italy	Ospedale Cardinal Massai	Asti	AT
Italy	Ospedali Riuniti di Bergamo	Bergamo	BG
Italy	Policlinico S.Orsola- Malpighi	Bologna	BO
Italy	Ospedale Ferrarotto	Catania	CT
Italy	Ospedale S. Anna	Ferrara	FE
Italy	USL 9 Grosseto	Grosseto	GR
Italy	Ospedale Civile	Mirano	VE
Italy	Policlinico Padova	Padova	PD
Italy	Policlinico Parma	Parma	PR
Italy	Policlinico Gemelli	Rome
Italy	Policlinico Le Scotte	Siena	SI
Italy	Ospedale Le Molinette	Torino	TO
Italy	Ospedale Mauriziano	Torino	TO
Italy	Ospedale San Giovanni Bosco	Torino	TO

Sponsors (2)

Lead Sponsor	Collaborator
Italian Society of Invasive Cardiology	Meditrial SrL

Country where clinical trial is conducted

Italy, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Percentage of ruptured or eroded plaques at infarct related lesion as assessed by OCT before PCI	To assess gender differences in the percentage of ruptured or eroded plaques at infarct related lesion as assessed by OCT. The OCT measurement is taken before stenting, when a TIMI flow 2-3 is detected. If baseline flow is TIMI 1, thrombus aspiration is performed before OCT.	Plaque rupture is evaluated during the index PCI procedure.	No
Primary	Percent of covered stent struts by OCT in infarct-related lesion at 9 months (co-primary endpoint).	To assess gender differences in the percentage of covered stent struts at infarct related lesion as assessed by OCT performed in all patients at 9 months.	Stent coverage is evaluated at 9 months by OCT performed in all patients.	Yes
Secondary	Minimal Fibrous Cap Thickness (MFCA) (µm) at infarct-related lesion as determined by OCT.	To assess gender differences in Minimal Fibrous Cap Thickness at infart related lesion by OCT immediataly after reestablishment of TIMI (Thrombolysis In Myocardial Infarction) 2-3 coronary blood flow and before stent implantation.; The evolution of fibrous cap thickness over time will be determined by OCT that will be performed in all patients at 9 months from the index procedure.	MFCA at index procedure (immediately after reestablishment of TIMI 2-3 coronary flow by PCI) and at 9 months OCT performed in all patients.	No
Secondary	Presence and type of residual thrombus material in the culprit vessel.	To assess gender differences in thrombus type by OCT in culprit vessel after reestablishment of TIMI (Thrombolysis In Myocardial Infarction) 2-3 coronary blood flow and before stent implantation.	Residual thrombus in the infarct related vessel is evaluated during the index procedure: immediately after reestablishment of TIMI 2-3 coronary flow during primary percutaneous coronary intervention	No
Secondary	Number of TCFA (<65 µM) as assessed by OCT in the culprit vessel (infarct related).	To assess gender difference in TCFA number as assessed by OCT in the infarct related vessel during the index procedure and at 9 months by OCT performed in all patients	Thin Fibrous Cap Atheroma is assessed during the index procedure: immediately after reestablishment of TIMI 2-3 coronary flow before stent implantationduring PCI; and at 9 months by OCT performed in all patients.	No
Secondary	percent of malapposed-uncovered struts	to assess gender difference in % malapposed/uncovered struts at 9 months follow up by OCT	9 months	Yes
Secondary	percent net volume obstruction	To assess gender difference in % of stent volume obstruction by OCT at 9 months follow up	9 months	No
Secondary	percent abnormal intraluminal tissue	To assess gender difference in % of abnormal intraluminal tissue by OCT at 9 months follow up	9 months	Yes

External Links

•   This site provides general information about the study, progress updates and contact information.